US$ 20.98
igf 1 lr3 human trial QK041 Recombinant Human LR3 IGF-I/IGF-1 Protein,
Description
doi: 10.3390/plants12173034 232 ZorbC.HerbstR.ForreiterC.SchubertS

Starobova et al., 2019)

In addition, you can get a 50% discount on your order if you buy 50 units or more

Combining antioxidant-targeting agents with cell wall synthesis inhibitors has shown synergistic efficacy in model organisms, supporting combination therapies
